Pancreatic cancer is deadly because it is usually diagnosed when it is already advanced, Stage IV, with metastases all over, ...
Novo-Nordisk A/S NVO shares traded higher by more than 6% on Monday as GLP‑1 support initiatives aimed at improving access and persistence on therapy kept the weight-loss drug category in focus.
MedPage Today on MSN
Newer Diabetes Drugs, Including GLP-1 Agonists, Tied to Autoimmunity Risk
Patterns differ among medication classes; potential mechanisms need more research ...
Cardiovascular disease associated with type 2 diabetes (T2DM) has become a major issue in the development of novel T2DM therapies. Now, the US Food and Drug Administration (FDA) has issued a final ...
The US is in the middle of an estrogen patch shortage, with menopausal women struggling to get ahold of hormone therapy to stave off their symptoms — and experts don’t think the problem’s likely to ...
We may receive a commission on purchases made from links. When the weather is nice, it's an ideal time to give your outdoor furniture a good, thorough clean to remove any stains and get ready to ...
Congenital heart disease (CHD) is the most common congenital anomaly, with lifelong implications as survival into adulthood ...
A significant breakthrough in heart disease prevention arrived on July 16, 2026, with the FDA approval of Lipfendra ...
Since we first published this list, a few big names have signed deals (Austin Reaves, Trae Young, Isaiah Hartenstein), yet the biggest names are still on the board. Here is our updated list of the 15 ...
Lauren (Hansen) Holznienkemper is a lead editor for the small business vertical at Forbes Advisor, specializing in HR, payroll and recruiting solutions for small businesses. Using research and writing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results